• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 2009

View Archived Issues

FYX-051 shows potent serum uric acid-lowering activity in rats

Read More

AstraZeneca reports results from third quarter of 2009

Read More

Dainippon Sumimoto reports results from Q2 of the year ending March 31, 2010

Read More

Analyses of phase III data detail activity of fidaxomicin against C. difficile infection

Read More

AST-120 improves pruritus in patients with chronic liver disease

Read More

ITMN-191 monotherapy for HCV infection correlates with high barrier to viral escape

Read More

BMS-650032 shows potent anti-HCV activity in two phase II trials

Read More

Schering-Plough claims gamma-secretase modulators for AD therapy

Read More

arGentis to initiate first-in-human clinical trial of ARG-301 in rheumatoid arthritis

Read More

Adeona launches CopperProof Test for AD and cognitive impairment

Read More

PulmoBind has potential to diagnose conditions affecting pulmonary circulation

Read More

Pikamab to customize cancer antibody therapies with ADCC Therasight

Read More

Hybrigenics to meet with EMEA to discuss phase II trial of inecalcitol

Read More

Astex Therapeutics and GSK enter into strategic drug discovery alliance

Read More

Clinuvel to file MAA with EMEA for its photoprotective drug afamelanotide

Read More

Diamyd Medical completes enrollment in a phase III trial of Diamyd

Read More

First patient treated in phase IIb trial of 4SC-101 in rheumatoid arthritis

Read More

Bristol-Myers Squibb and Alder Biopharmaceuticals enter global RA biologic agreement

Read More

Avanir presents safety and efficacy data from STAR trial of Zenvia in PBA

Read More

Novel PI3K and mTOR inhibitors described by Wyeth as oncolytics

Read More

Novartis developing novel protease inhibitors for AD and other conditions

Read More

Merck KGaA reports dual-acting 5-HT reuptake inhibitors/5-HT1A receptor agonists

Read More

Phase I/II data show VIR-576 to be safe and effective in HIV

Read More

Promising preclinical and phase IIa data on S/GSK-1349572 disclosed

Read More

Bristol-Myers Squibb to split off its holdings in Mead Johnson

Read More

Merck & Co. completes enrollment in phase III clinical trial of SCH-530348

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • U.S. Capitol building, Washington D.C.

    House passes H.R. 1, restoring R&D tax cuts

    BioWorld MedTech
    The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe